The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom
Abstract Introduction Data on the burden of hypereosinophilic syndrome (HES) are limited. This study investigated the incidence and prevalence of HES using real‐world data from patients in the United Kingdom. Methods Primary care data from the Clinical Practice Research Datalink were analyzed. The p...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb846459b2d146bca141be52aa8e96d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bb846459b2d146bca141be52aa8e96d5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bb846459b2d146bca141be52aa8e96d52021-11-12T19:57:15ZThe increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom2050-452710.1002/iid3.495https://doaj.org/article/bb846459b2d146bca141be52aa8e96d52021-12-01T00:00:00Zhttps://doi.org/10.1002/iid3.495https://doaj.org/toc/2050-4527Abstract Introduction Data on the burden of hypereosinophilic syndrome (HES) are limited. This study investigated the incidence and prevalence of HES using real‐world data from patients in the United Kingdom. Methods Primary care data from the Clinical Practice Research Datalink were analyzed. The patients of interest were identified using medical codes specific for HES. Annual incidence rates and prevalence were estimated for the years 2010–2018 (inclusive) using patients observed for a minimum period of one year. Results Between 2010 and 2018, 93 patients were identified with HES. During the study period the incidence of HES ranged from less than 0.04, 95% confidence interval (CI) (0.01–0.07) to 0.17, 95% CI (0.10–0.26) per 100,000 person‐years and the prevalence ranged from 0.15, 95% CI (0.10–0.25) to 0.89, 95% CI (0.74–1.09) cases per 100,000 persons. Sensitivity analyses varying the minimum observation period required to identify HES patients gave similar results. Conclusion These results provide estimates of the burden of HES in the United Kingdom and indicate that whilst HES is a very rare disease, there is evidence that is increasingly being recorded in UK primary care.Gema RequenaJohn LogieDaniel C. GibbonsJonathan SteinfeldMelissa K. Van DykeWileyarticlehypereosinophilic syndromeincidenceprevalenceUnited KingdomImmunologic diseases. AllergyRC581-607ENImmunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1447-1451 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hypereosinophilic syndrome incidence prevalence United Kingdom Immunologic diseases. Allergy RC581-607 |
spellingShingle |
hypereosinophilic syndrome incidence prevalence United Kingdom Immunologic diseases. Allergy RC581-607 Gema Requena John Logie Daniel C. Gibbons Jonathan Steinfeld Melissa K. Van Dyke The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom |
description |
Abstract Introduction Data on the burden of hypereosinophilic syndrome (HES) are limited. This study investigated the incidence and prevalence of HES using real‐world data from patients in the United Kingdom. Methods Primary care data from the Clinical Practice Research Datalink were analyzed. The patients of interest were identified using medical codes specific for HES. Annual incidence rates and prevalence were estimated for the years 2010–2018 (inclusive) using patients observed for a minimum period of one year. Results Between 2010 and 2018, 93 patients were identified with HES. During the study period the incidence of HES ranged from less than 0.04, 95% confidence interval (CI) (0.01–0.07) to 0.17, 95% CI (0.10–0.26) per 100,000 person‐years and the prevalence ranged from 0.15, 95% CI (0.10–0.25) to 0.89, 95% CI (0.74–1.09) cases per 100,000 persons. Sensitivity analyses varying the minimum observation period required to identify HES patients gave similar results. Conclusion These results provide estimates of the burden of HES in the United Kingdom and indicate that whilst HES is a very rare disease, there is evidence that is increasingly being recorded in UK primary care. |
format |
article |
author |
Gema Requena John Logie Daniel C. Gibbons Jonathan Steinfeld Melissa K. Van Dyke |
author_facet |
Gema Requena John Logie Daniel C. Gibbons Jonathan Steinfeld Melissa K. Van Dyke |
author_sort |
Gema Requena |
title |
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom |
title_short |
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom |
title_full |
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom |
title_fullStr |
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom |
title_full_unstemmed |
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom |
title_sort |
increasing incidence and prevalence of hypereosinophilic syndrome in the united kingdom |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/bb846459b2d146bca141be52aa8e96d5 |
work_keys_str_mv |
AT gemarequena theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT johnlogie theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT danielcgibbons theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT jonathansteinfeld theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT melissakvandyke theincreasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT gemarequena increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT johnlogie increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT danielcgibbons increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT jonathansteinfeld increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom AT melissakvandyke increasingincidenceandprevalenceofhypereosinophilicsyndromeintheunitedkingdom |
_version_ |
1718430339162963968 |